Genomics for the Prevention (and Reversal) of Cognitive Decline

Sharon Hausman-Cohen


Heather Sandison, N.D.

Welcome back to the Reverse Alzheimer’s Summit. I’m so excited to dive deep into the genetics that determine our risk for dementia. Dr. Sharon Hausman-Cohen is the Chief Medical Officer and Co-Founder of IntellxxDNA and Resilient Health in Austin, Texas. Dr. Hausman-Cohen has been in the field of integrative medicine for over 25 years. She and her co-founder developed IntellxxDNA as an answer to an unmet need in the integrative and functional medicine community. The need for accurate, evidence-based genomics tool geared at helping functional and integrative physicians practice personalized medicine. 

So many of us talk about this, but actually having the tools to do it is so important to making it happen. They envisioned and created a tool that could help identify root causes of cognitive decline, environmentally acquired illness and other chronic illnesses. And one that could also help clinicians know how to adjust these genomic factors with lifestyle, diet, supplements, and occasionally even medications. The IntellxxDNA clinical decision support tool is now being used as an integral part of medical decision-making by integrative and functional medicine clinicians across the country. IntellxxDNA is also the genomics used in the study that is currently pending publication by Dr. Dale Bredesen and his colleagues. Dr. Hausman-Cohen, thank you so much for taking the time to join us. Welcome.

Related Videos

The Science Of Slumber: How Low Oxygen Levels At Night Can Lead To Memory Loss And Dementia OR Elixer Of Life: Oxygen Therapy For Brain Function And Detox​

Mark Squibb

Mold & Detox

Margaret Christensen, MD

Purchase Now




Login to get access to DrSummits wide selection of expert videos, your summit or video purchases.


Your cart is currently empty.

Return to shop

Sign up


Already have an account? Log In